| Ronald G Grifka, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Ronald G Grifka |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386624666 | NPI | - | NPPES |
| 1558407189 | Other | MI | GROUP NPI |
| 0D16078136 | Other | MI | MEDICARE PTAN |
| D16256055 | Other | MI | GROUP # |
| 350D176310 | Other | MI | BCBSM |
| 4793463 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4301405835 (Michigan) | Secondary |
| 2080P0202X | Pediatrics - Pediatric Cardiology | 4301405835 (Michigan) | Primary |
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele - the most prevalent genetic risk for Alzheimer's disease - upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism. And after a patient has dealt with these dangerous blood clots once, a second and subsequent events become much more likely.
A recent analysis of ancient DNA has revealed that the plaque had been endemic in humans for at least 3000 years before the first global outbreak on record (the Plague of Justinian in 541 AD). Furthermore, the disease was not always transmitted by fleas, with mutation to the bubonic form only occurring around the start of the 1st millennium BC.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
Loyola University Medical Center is enrolling melanoma patients in the first clinical trial in the Midwest of an experimental vaccine that trains a patient's immune system to fight the deadly cancer.
› Verified 2 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952331936 PECOS PAC ID: 3779496856 Enrollment ID: O20031117000265 |
News Archive
A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele - the most prevalent genetic risk for Alzheimer's disease - upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism. And after a patient has dealt with these dangerous blood clots once, a second and subsequent events become much more likely.
A recent analysis of ancient DNA has revealed that the plaque had been endemic in humans for at least 3000 years before the first global outbreak on record (the Plague of Justinian in 541 AD). Furthermore, the disease was not always transmitted by fleas, with mutation to the bubonic form only occurring around the start of the 1st millennium BC.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
Loyola University Medical Center is enrolling melanoma patients in the first clinical trial in the Midwest of an experimental vaccine that trains a patient's immune system to fight the deadly cancer.
› Verified 2 days ago
| Entity Name | Metropolitan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811937519 PECOS PAC ID: 5597651836 Enrollment ID: O20040507000012 |
News Archive
A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele - the most prevalent genetic risk for Alzheimer's disease - upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism. And after a patient has dealt with these dangerous blood clots once, a second and subsequent events become much more likely.
A recent analysis of ancient DNA has revealed that the plaque had been endemic in humans for at least 3000 years before the first global outbreak on record (the Plague of Justinian in 541 AD). Furthermore, the disease was not always transmitted by fleas, with mutation to the bubonic form only occurring around the start of the 1st millennium BC.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
Loyola University Medical Center is enrolling melanoma patients in the first clinical trial in the Midwest of an experimental vaccine that trains a patient's immune system to fight the deadly cancer.
› Verified 2 days ago
| Entity Name | Dlp Marquette Physician Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487902995 PECOS PAC ID: 9931359601 Enrollment ID: O20121016000312 |
News Archive
A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele - the most prevalent genetic risk for Alzheimer's disease - upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism. And after a patient has dealt with these dangerous blood clots once, a second and subsequent events become much more likely.
A recent analysis of ancient DNA has revealed that the plaque had been endemic in humans for at least 3000 years before the first global outbreak on record (the Plague of Justinian in 541 AD). Furthermore, the disease was not always transmitted by fleas, with mutation to the bubonic form only occurring around the start of the 1st millennium BC.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
Loyola University Medical Center is enrolling melanoma patients in the first clinical trial in the Midwest of an experimental vaccine that trains a patient's immune system to fight the deadly cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald G Grifka, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Ronald G Grifka, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele - the most prevalent genetic risk for Alzheimer's disease - upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
It's the third deadliest cardiovascular diagnosis, but doctors are still often stumped to explain why 40% of patients experience unprovoked venous thromboembolism. And after a patient has dealt with these dangerous blood clots once, a second and subsequent events become much more likely.
A recent analysis of ancient DNA has revealed that the plaque had been endemic in humans for at least 3000 years before the first global outbreak on record (the Plague of Justinian in 541 AD). Furthermore, the disease was not always transmitted by fleas, with mutation to the bubonic form only occurring around the start of the 1st millennium BC.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
Loyola University Medical Center is enrolling melanoma patients in the first clinical trial in the Midwest of an experimental vaccine that trains a patient's immune system to fight the deadly cancer.
› Verified 2 days ago
Dr. Michael Edmund Watson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Joanna Van Beek, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, D3238 Mpb Spc 5718, Ann Arbor, MI 48109 Phone: 734-763-5589 Fax: 734-763-4208 | |
Ashleigh Grund El Sakr, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4900 Jackson Rd Ste A, Ann Arbor, MI 48103 Phone: 734-998-7380 | |
Jennifer Rose Blase, MD, PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Vishvanie Bernadene Stoody, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Maysa Hamade, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Alejandro Velez Lopez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |